Referencias:
1CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus(2015)
2.Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system (2017)
3.Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo (2018)
4. In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. (2016)
sábado, 15 de diciembre de 2018
miércoles, 5 de diciembre de 2018
domingo, 2 de diciembre de 2018
Suscribirse a:
Entradas (Atom)